α-1b干扰素联合布地奈德、氨溴索雾化吸入治疗小儿支气管肺炎疗效观察  

The effect of α-1B interferon combined with budesonide and ambroxol atomization inhalation in the treatment of 440 cases of children with bronchopneumonia

作　　者：钱三建 Qian Sanjian(Neonatal Department,the Maternal and Child Health Hospital of Jingzhou City,Hubei,Jingzhou 434020)

机构地区：[1]荆州市妇幼保健院新生儿科

出　　处：《中国社区医师》2019年第34期48-49,共2页Chinese Community Doctors

摘　　要：目的:探讨α-1b干扰素联合布地奈德、氨溴索雾化吸入治疗小儿支气管肺炎的临床疗效。方法:2018年6月-2019年6月收治小儿支气管肺炎患儿220例,随机分为两组各110例。对照组给予常规治疗,观察组在常规治疗基础上进行雾化吸入治疗。比较两组临床症状改善时间和住院时间。结果:观察组临床症状改善时间和住院时间均显著低于对照组,差异有统计学意义(P<0.05)。结论:α-1b干扰素联合布地奈德、氨溴索雾化吸入治疗小儿支气管炎具有恢复快、安全性高、住院时间短等优点,值得在临床推广。Objective:To explore the effect ofα-1B interferon combined with budesonide and ambroxol atomization inhalation in the treatment of 220 cases of children with bronchopneumonia.Methods:From June 2018 to June 2019,we selected 440 cases of children with bronchopneumonia,who were randomly divided into two groups of 110 cases in each.The control group was treated with conventional treatment,and the observation group was treated with aerosol inhalation on the basis of conventional treatment.We compared the improvement time of clinical symptoms and hospitalization time of the two groups.Results:In the observation group,the improvement time of clinical symptoms and hospitalization time were significantly lower than those in the control group,the difference was statistically significant(P<0.05).Conclusion:The application ofα-1B interferon combined with budesonide and ambroxol atomization inhalation in the treatment of children with bronchopneumonia had the advantages of fast recovery,high safety and short hospital stay,it was worth popularizing in clinical practice.

关 键 词：Α-1B干扰素 布地奈德 盐酸氨溴索 雾化吸入 小儿支气管肺炎 

分 类 号：R72[医药卫生—儿科]